An aid to evaluate patients suspected of having systemic mastocytosis
Systemic mastocytosis (SM) is a heterogeneous disorder, including N-methylhistamine (NMH), and 11 beta-prostaglandin F2 alpha (23BPG) provides a clinical sensitivity >90% and specificity >60%.
|Test ID||Reporting Name||Available Separately||Always Performed|
When leukotriene E4 testing is performed, urine creatinine will always be performed at no additional charge.
LTE4: Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS)
AACT: Enzymatic Colorimetric Assay
Leukotriene E4, U
Systemic Mast Cell Activation
Mast Cell Activation Syndrome